- Prescription Drug User Fee Act (PDUFA) action date set for March 12, 2023, for trofinetide for the treatment of Rett syndrome SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), ...
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2022. First Quarter Highlights First Quarter ...
This year’s iteration of the organization’s annual conference, dubbed “Hybrids & Haecceities,” will be hosted by the Weitzman School in Philadelphia after being delayed two full years (the school was ...
It’s easy to leave a week jam-packed with cutting-edge research feeling optimistic about the various futures that the architectural discipline holds before us. But maybe that optimism has less to do ...
Good morning and welcome to Acadia Healthcare's Fourth Quarter and Full Year 2022 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, ...
From a segment share standpoint, the Acadia held just a three percent share, up one percentage point. The Explorer led with a 12 percent segment share, up three percentage points while the Highlander ...
GMC Acadia sales increased in Canada and Mexico while decreasing in the United States during the second quarter of 2022. GMC Acadia Sales - Q2 2022 - United States In the United States, GMC Acadia ...
• EBITDA: net income attributable to Acadia Healthcare Company, Inc. adjusted for net income attributable to noncontrolling interests, loss from discontinued operations, net of taxes, provision for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results